Overview

COnventional vs. Optimised PERiprocedural Analgosedation vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)

Status:
Recruiting

Trial end date:
2025-02-01

Target enrollment:

Participant gender:

Summary

A prospective single blinded (subject blinded) 1:1:1 randomised control trial with three parallel arms testing superiority of analgosedation regimen based on remimazolam and total intravenous anesthesia over propofol based analgosedation. The primary composite endpoint consists of hypoxaemia, hypotension, or hypertension requiring intervention.

Phase:

Phase 3

Details

Lead Sponsor:

Charles University, Czech Republic

Treatments:

Propofol